The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

This approach aims to improve treatment for patients with this highly aggressive and treatment-resistant type of breast ...

NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...

BofA has initiated coverage of Candel Therapeutics (NASDAQ:CADL) with a buy rating, citing the potential of its immunotherapy drug candidates CAN-2409 and CAN-3110. "While approved therapies may have ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

Are the green shoots starting to emerge for the junior market? Well, it certainly seems to be the case with a rash of fundraisers.